Original Article
Diagnostic performance of diffusion-weighted magnetic resonance imaging in pulmonary malignant lesions: a meta-analysis
Translational Lung Cancer Research
2019;
8
(6)
:738-747
.
(31 December 2019)
Characterization of PD-L1 protein expression and CD8+ tumor-infiltrating lymphocyte density, and their associations with clinical outcome in small-cell lung cancer
Translational Lung Cancer Research
2019;
8
(6)
:748-759
.
(31 December 2019)
Silence of S1 RNA binding domain 1 represses cell growth and promotes apoptosis in human non-small cell lung cancer cells
Translational Lung Cancer Research
2019;
8
(6)
:760-774
.
(31 December 2019)
Sleeve lobectomy compared with pneumonectomy for operable centrally located non-small cell lung cancer: a meta-analysis
Translational Lung Cancer Research
2019;
8
(6)
:775-786
.
(31 December 2019)
Flexible bronchoscopy-guided microwave ablation in peripheral porcine lung: a new minimally-invasive ablation
Translational Lung Cancer Research
2019;
8
(6)
:787-796
.
(31 December 2019)
Screening of potential biomarkers and their predictive value in early stage non-small cell lung cancer: a bioinformatics analysis
Translational Lung Cancer Research
2019;
8
(6)
:797-807
.
(31 December 2019)
Prognostic effects of glycometabolism changes in lung adenocarcinoma: a prospective observational study
Translational Lung Cancer Research
2019;
8
(6)
:808-819
.
(31 December 2019)
Comparison of robotic-assisted lobectomy with video-assisted thoracic surgery for stage IIB–IIIA non-small cell lung cancer
Translational Lung Cancer Research
2019;
8
(6)
:820-828
.
(31 December 2019)
Irinotecan, topotecan, paclitaxel or docetaxel for second-line treatment of small cell lung cancer: a single-center retrospective study of efficiency comparation and prognosis analysis
Translational Lung Cancer Research
2019;
8
(6)
:829-837
.
(31 December 2019)
Genetic alteration profile of EGFR-mutant resected IIB–IIIA stage NSCLC and correlation to clinical outcomes
Translational Lung Cancer Research
2019;
8
(6)
:838-846
.
(31 December 2019)
The role of the gut microbiome on the efficacy of immune checkpoint inhibitors in Japanese responder patients with advanced non-small cell lung cancer
Translational Lung Cancer Research
2019;
8
(6)
:847-853
.
(31 December 2019)
Circulating tumor cells in lung cancer are prognostic and predictive for worse tumor response in both targeted- and chemotherapy
Translational Lung Cancer Research
2019;
8
(6)
:854-861
.
(31 December 2019)
Circ-ZKSCAN1 regulates FAM83A expression and inactivates MAPK signaling by targeting miR-330-5p to promote non-small cell lung cancer progression
Translational Lung Cancer Research
2019;
8
(6)
:862-875
.
(31 December 2019)
CT-based radiomics signature for the stratification of N2 disease risk in clinical stage I lung adenocarcinoma
Translational Lung Cancer Research
2019;
8
(6)
:876-885
.
(31 December 2019)
Prognostic biomarkers in stage IV non-small cell lung cancer (NSCLC): neutrophil to lymphocyte ratio (NLR), lymphocyte to monocyte ratio (LMR), platelet to lymphocyte ratio (PLR) and advanced lung cancer inflammation index (ALI)
Translational Lung Cancer Research
2019;
8
(6)
:886-894
.
(31 December 2019)
T cell immunoglobulin and mucin-domain containing-3 in non-small cell lung cancer
Translational Lung Cancer Research
2019;
8
(6)
:895-906
.
(31 December 2019)
Prognostic model based on circular RNA circPDK1 for resected lung squamous cell carcinoma
Translational Lung Cancer Research
2019;
8
(6)
:907-919
.
(31 December 2019)
Analysis of the association between prior chemotherapy regimens and outcomes of subsequent anti-PD-(L)1 monotherapy in advanced non-small cell lung cancer
Translational Lung Cancer Research
2019;
8
(6)
:920-928
.
(31 December 2019)
Three-dimensional printing in the preoperative planning of thoracoscopic pulmonary segmentectomy
Translational Lung Cancer Research
2019;
8
(6)
:929-937
.
(31 December 2019)
Comparative expression analysis in small cell lung carcinoma reveals neuroendocrine pattern change in primary tumor versus lymph node metastases
Translational Lung Cancer Research
2019;
8
(6)
:938-950
.
(31 December 2019)
Robot-assisted thoracoscopic surgery versus thoracotomy for c-N2 stage NSCLC: short-term outcomes of a randomized trial
Translational Lung Cancer Research
2019;
8
(6)
:951-958
.
(31 December 2019)
Cyclin D1 expression as a potential prognostic factor in advanced KRAS-mutant non-small cell lung cancer
Translational Lung Cancer Research
2019;
8
(6)
:959-966
.
(31 December 2019)
Patterns and risks of postoperative recurrence in completely resected EGFR-mutant non-small cell lung cancer: prognostic significance of routine immunohistochemical markers
Translational Lung Cancer Research
2019;
8
(6)
:967-978
.
(31 December 2019)
Differentiation of non-small cell lung cancer and histoplasmosis pulmonary nodules: insights from radiomics model performance compared with clinician observers
Translational Lung Cancer Research
2019;
8
(6)
:979-988
.
(31 December 2019)
Biosimilar candidate IBI305 plus paclitaxel/carboplatin for the treatment of non-squamous non-small cell lung cancer
Translational Lung Cancer Research
2019;
8
(6)
:989-999
.
(31 December 2019)
Promoter methylation status of ASC/TMS1/PYCARD is associated with decreased overall survival and TNM status in patients with early stage non-small cell lung cancer (NSCLC)
Translational Lung Cancer Research
2019;
8
(6)
:1000-1015
.
(31 December 2019)
Parallel serial assessment of somatic mutation and methylation profile from circulating tumor DNA predicts treatment response and impending disease progression in osimertinib-treated lung adenocarcinoma patients
Translational Lung Cancer Research
2019;
8
(6)
:1016-1028
.
(31 December 2019)
Efficacy of rapid on-site evaluation for diagnosing pulmonary lesions and mediastinal lymph nodes: a systematic review and meta-analysis
Translational Lung Cancer Research
2019;
8
(6)
:1029-1044
.
(31 December 2019)
Presence of allele frequency heterogeneity defined by ctDNA profiling predicts unfavorable overall survival of NSCLC
Translational Lung Cancer Research
2019;
8
(6)
:1045-1050
.
(31 December 2019)
Extracellular vesicle-based EGFR genotyping in bronchoalveolar lavage fluid from treatment-naive non-small cell lung cancer patients
Translational Lung Cancer Research
2019;
8
(6)
:1051-1060
.
(31 December 2019)
Discovery of lung surface intersegmental landmarks by three-dimensional reconstruction and morphological measurement
Translational Lung Cancer Research
2019;
8
(6)
:1061-1072
.
(31 December 2019)
Brief Report
Type 2 diabetes mellitus does not increase the risk of lung cancer among never-smokers: a nationwide cohort study
Translational Lung Cancer Research
2019;
8
(6)
:1073-1077
.
(31 December 2019)
Evaluation of the lung immune prognostic index in advanced non-small cell lung cancer patients under nivolumab monotherapy
Translational Lung Cancer Research
2019;
8
(6)
:1078-1085
.
(31 December 2019)
Study Protocol
Rationale and design of a phase II trial of osimertinib as first-line treatment for elderly patients with epidermal growth factor receptor mutation-positive advanced non-small cell lung cancer (SPIRAL-0 study)
Translational Lung Cancer Research
2019;
8
(6)
:1086-1090
.
(31 December 2019)
Review Article
Advances in clinical trials of targeted therapy and immunotherapy of lung cancer in 2018
Translational Lung Cancer Research
2019;
8
(6)
:1091-1106
.
(31 December 2019)
Mechanisms of resistance to pemetrexed in non-small cell lung cancer
Translational Lung Cancer Research
2019;
8
(6)
:1107-1118
.
(31 December 2019)
Targeting BRAF mutations in non-small cell lung cancer
Translational Lung Cancer Research
2019;
8
(6)
:1119-1124
.
(31 December 2019)
Toxicity of tumor immune checkpoint inhibitors—more attention should be paid
Translational Lung Cancer Research
2019;
8
(6)
:1125-1133
.
(31 December 2019)
The optional approach of oncogene-addicted non-small cell lung cancer with brain metastases in the new generation targeted therapies era
Translational Lung Cancer Research
2019;
8
(6)
:1134-1151
.
(31 December 2019)
Case Report
Transesophageal needle aspiration using a third-generation Olympus ultrasound bronchoscope for subaortic lesions: a report of two cases
Translational Lung Cancer Research
2019;
8
(6)
:1152-1156
.
(31 December 2019)
Cancer stem-neuroendocrine cells in an atypical carcinoid case report
Translational Lung Cancer Research
2019;
8
(6)
:1157-1162
.
(31 December 2019)
Consensus
Society for Translational Medicine consensus on postoperative management of EGFR-mutant lung cancer (2019 edition)
Translational Lung Cancer Research
2019;
8
(6)
:1163-1173
.
(31 December 2019)
Guideline
Clinical guidelines on perioperative management strategies for enhanced recovery after lung surgery
Translational Lung Cancer Research
2019;
8
(6)
:1174-1187
.
(31 December 2019)
